A positive consequence the pandemic has caused, was the speed with which various countries around the world were able to develop vaccines.
This was possible thanks to the know-how, innovation, and technology that each nation housed. Certainly though, in order to be able to carry out the production of millions of vaccines, cooperation and technology sharing was imperative between many countries.
Despite this titanic achievement, in other aspects of the health industry, much was left lacking. According to the Harvard Business Review from 2021, this industry is under tremendous pressure globally to optimize their clinical and operational processes and to accelerate their digital transformation, in order to answer to the growing demand for more personalized, improved and patient centric health services.
To manage this change, various collaboration models have come up between large corporations, startups, government entities and nonprofit organizations. A recent example is the alliance between the pharmaceutical giant Pfizer and the biotechnology company BioNTech that developed a vaccine against COVID-19 in record time.
Disruptive innovation: The PillPack - IDEO Case
Another famous alliance case was the North American company PillPack and the international design nonprofit consultancy IDEO that has an incubator program for startups. PillPack was born in 2013. It sells and distributes prescription medication online through a digital platform. This innovative idea revolutionized the prescription medication market and five years after its creation was bought by Amazon for almost 1 million dollars US.
Their service consists of preparing individualized packages with a daily dose of medication and supplements with their respective dates and ingestion times, which are delivered to one’s home. This is an innovative example focused on elderly patients that can forget to take medication or have difficulty opening bottles, but it also aims at another kind of patient, such as young people with chronic diseases and active lives who must take daily medicine.
It’s a simple idea, that improves the user’s health.Another interesting aspect of this company is that it’s related to economic efficiency, because by sending the product directly to the buyer’s home, the accumulation of prescription medication in pharmacies due to people who failed to pick them up, is avoided. This happens with frequency in the US and creates an annual loss of US$ 290 million.
International profile, local partners
Technology is an essential tool in the health industry. Specifically in the Pharma and Internet of Things (IoT) its key to count on a net of partners and strategic associates because the services being sought are very specialized and at the same time, clients prefer a company that takes care of the whole process of creation: from the idea up to the implementation, which also includes issues from user experience to the dashboard metrics of usability, etc.
In the 15 years that DMO design company has existed, we have made innumerable strategic alliances in the Pharma, IoT, Health Care, culture sectors and many more.
One of our strengths is our international profile through local partners, such as our collaboration with Hecho Company from Spain, which resulted in an immersive art experience at Casa Batlló and with the IBM IoT Lab in the application of our service design methodologies.
Also, we carried out various projects with our technological partner Globons,with whom we developed an early detection app for people with a prevalency for cardiac insufficiency called PulseApp as well as an app called MeUp centred on Gamification to improve the "treatment journey" for transplant patients.
Recently we created a partnership with a global leader in technology and software, Stefanini, who is present in more than 40 countries while being committed to continuing co-creating Design+Innovation+TEchnology services focused on the continual transformation of the regional Pharma industry.
This co-creation project with IBM was interesting because it resulted in the implementation of our innovation sprints method,a tool normally used in software development, that we specially adapted for the IoT Lab. This enriching interdisciplinary path where various sectors and methodologies are benefited, is in our DNA.
Our global co-creations net, founded on clients and partners from countries that are central to innovation, allows us to be in the cutting edge of development tools, methodologies, and technologies,as well as tendencies in products and services centered around people to improve their quality of life.
It is of paramount importance to DMO to participate actively in the startup ecosystem in the US and Latin America. We are members of the global technology entrepreneurs“Hackers & Founders”.The year we mentored the startup Bone Health Technologies,that created a vibratory belt to prevent osteoporosis and whose ideawon the “Grand Prize” at the national startups’ competition organized by Harvard Business School. In San Francisco, California, we are design partners with the main accelerators for hardware startups like DraperU, Hardware Massive and Hax. In Chile, this year we collaborated with the incubator for startups, Chrysalis and thanks to them we won two new clients.
In the world of technology, it is common to have the road map change vertiginously and that is exactly what motivated us to co-create products and services that improve people’s quality of life. This was the case with Clonify, that started by being a digital tool centered on users with rare and and chronic diseases that transformed into a platform for eHealth service, which then quickly grew thanks to the alliance established with the global tech company Stefanini.
Another emblematic case for DMO was that of Biobot, that began producing intelligent devices for the IoT market and ended up creating Iotly,a hub of complementary companies that provide development, implementation, production, and services in Iot for multiple industries.
Lastly, we carried out various projects with our technological partner Globbons, with whom we developed and app for people with cardiac insufficiency called PulseApp and an app for transplant patients called MeUP. The creative possibilities in the universe of innovation are infinite and every solution that we find motivates us to make the world we live in better for everyone.
Do you have projects in mind? We can co-create together..
See you on our next post from DMO Lab!